|
MPH (n = 16)
|
ATX (n = 14)
|
p value
|
---|
Pre-
|
Post-
|
Pre-
|
Post-
|
MPH
|
ATX
| |
---|
Mean (SD)
|
Mean (SD)
|
Mean (SD)
|
Mean (SD)
|
Pre vs posta
|
Pre vs posta
|
Time × Drug Interactionb
|
---|
ARF
|
30.63 (10.65)
|
17.06 (10.51)
|
32.29 (13.46)
|
22.71 (10.54)
|
0.000
|
0.001
|
0.208
|
ARI
|
16.75 (5.52)
|
10.13 (6.01)
|
18.29 (6.84)
|
13.71 (6.27)
|
0.000
|
0.010
|
0.272
|
ARH
|
13.88 (6.72)
|
6.94 (5.47)
|
14.00 (7.99)
|
9.00 (4.84)
|
0.000
|
0.002
|
0.295
|
SCWC-1
|
18.31 (7.66)
|
27.75 (11.70)
|
25.86 (8.76)
|
33.79 (13.57)
|
0.000
|
0.000
|
0.520
|
SCWC-2
|
19.81 (9.56)
|
28.13 (10.54)
|
29.36 (11.11)
|
33.50 (12.82)
|
0.000
|
0.033
|
0.098
|
SCWC-3
|
21.19 (9.17)
|
26.44 (10.91)
|
25.36 (10.35)
|
34.07 (12.16)
|
0.006
|
0.002
|
0.210
|
-
MPH methylphenidate, ATX atomoxetine, ARF ADHD RS IV-J full scores, ARI ADHD RS IV-J inattention subscale scores, ARH ADHD RS IV-J hyperactivity subscale scores, SCWC-1 Stroop color-word task number of correct answers first time, SCWC-2 Stroop color-word task number of correct answers second time, SCWC-3 Stroop color-word task number of correct answers third time
-
aTwo-tailed paired t test
-
bTwo-way factorial ANOVA